医学
涎腺导管癌
病态的
癌
外阴癌
多形性腺瘤癌
粘液表皮样癌
病理
腺样囊性癌
多形性腺瘤
内科学
唾液腺
作者
Ryo Kawata,Ichita Kinoshita,Tsuyoshi Jinnin,Masaaki Higashino,Tsuyoshi Takato,Yoshitaka Kurisu,Yoshinobu Hirose,Takeshi Tochizawa
出处
期刊:Research Square - Research Square
日期:2023-08-02
标识
DOI:10.21203/rs.3.rs-3183916/v1
摘要
Abstract Objective High-grade parotid carcinoma generally has a poor prognosis, and the histological type is mucoepidermoid carcinoma (MEC), salivary duct carcinoma (SDC), carcinoma ex pleomorphic adenoma (CEPA), or adenoid cystic carcinoma (AdCC) in the majority of cases. Methods During the 23-year period from September 1999 to December 2022, 250 patients with parotid carcinoma underwent initial treatment and had the histopathological type of their carcinoma. Retrospective study evaluated 111 MEC, SDC, CEPA, or AdCC cases among 134 patients with high-grade parotid carcinoma. We examined pathological and clinical features and prognosis, evaluated factors associated with recurrence, and performed immunohistological examinations. Results Pathological and clinical features and factors associated with recurrence were different for each histological type. The 10-year disease-free survival rates were as follows: MEC, 34.9%; SDC, 22.6%; CEPA, 47.1%; and AdCC, 56.3%. Human epidermal growth factor receptor type-2 and androgen receptor were positive in 48% and 56% of patients with SDC, respectively, 38% and 25% of those with CEPA. Conclusion Each histological type has its own pathological and clinical features, recurrence types, and tumor activities, suggesting that differentiating between high-grade parotid carcinomas according to histological type will improve diagnosis, and thus prognosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI